Michael Matson
Stock Analyst at Needham
(2.65)
# 2,095
Out of 4,947 analysts
23
Total ratings
69.23%
Success rate
11.46%
Average return
Main Sectors:
Stocks Rated by Michael Matson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TFX Teleflex | Maintains: Buy | $408 → $423 | $120.68 | +250.51% | 4 | Jan 31, 2020 | |
| INGN Inogen | Upgrades: Buy | $90 | $7.46 | +1,106.43% | 2 | Nov 6, 2019 | |
| MMSI Merit Medical Systems | Initiates: Buy | $53 | $85.51 | -38.02% | 1 | Apr 20, 2018 | |
| GMED Globus Medical | Upgrades: Buy | n/a | $60.57 | - | 1 | Apr 4, 2018 | |
| RMD ResMed | Upgrades: Hold | n/a | $284.89 | - | 1 | Jan 23, 2018 | |
| BSX Boston Scientific | Upgrades: Strong Buy | n/a | $103.17 | - | 1 | Dec 8, 2017 | |
| LIVN LivaNova | Upgrades: Buy | n/a | $53.72 | - | 2 | Sep 15, 2017 | |
| SYK Stryker | Upgrades: Hold | n/a | $381.91 | - | 4 | Aug 25, 2017 | |
| MBLY Mobileye Global | Downgrades: Hold | n/a | $14.01 | - | 1 | Mar 14, 2017 | |
| HOLX Hologic | Upgrades: Buy | n/a | $67.81 | - | 2 | Feb 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $80.08 | - | 1 | Aug 12, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.66 | - | 1 | Mar 3, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.56 | - | 1 | Feb 24, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $44.54 | - | 1 | Jan 29, 2016 |
Teleflex
Jan 31, 2020
Maintains: Buy
Price Target: $408 → $423
Current: $120.68
Upside: +250.51%
Inogen
Nov 6, 2019
Upgrades: Buy
Price Target: $90
Current: $7.46
Upside: +1,106.43%
Merit Medical Systems
Apr 20, 2018
Initiates: Buy
Price Target: $53
Current: $85.51
Upside: -38.02%
Globus Medical
Apr 4, 2018
Upgrades: Buy
Price Target: n/a
Current: $60.57
Upside: -
ResMed
Jan 23, 2018
Upgrades: Hold
Price Target: n/a
Current: $284.89
Upside: -
Boston Scientific
Dec 8, 2017
Upgrades: Strong Buy
Price Target: n/a
Current: $103.17
Upside: -
LivaNova
Sep 15, 2017
Upgrades: Buy
Price Target: n/a
Current: $53.72
Upside: -
Stryker
Aug 25, 2017
Upgrades: Hold
Price Target: n/a
Current: $381.91
Upside: -
Mobileye Global
Mar 14, 2017
Downgrades: Hold
Price Target: n/a
Current: $14.01
Upside: -
Hologic
Feb 15, 2017
Upgrades: Buy
Price Target: n/a
Current: $67.81
Upside: -
Aug 12, 2016
Downgrades: Hold
Price Target: n/a
Current: $80.08
Upside: -
Mar 3, 2016
Downgrades: Neutral
Price Target: n/a
Current: $1.66
Upside: -
Feb 24, 2016
Downgrades: Hold
Price Target: n/a
Current: $1.56
Upside: -
Jan 29, 2016
Upgrades: Buy
Price Target: n/a
Current: $44.54
Upside: -